Sewing KF |
Pharmacokinetics, dosing principles, and blood level monitoring of FK506. |
1994 |
Transplant. Proc. |
pmid:7527962
|
Frei U and Wagner K |
Renal function in liver transplant patients receiving FK506 or cyclosporin A immunosuppressive therapy. |
1994 |
Transplant. Proc. |
pmid:7527963
|
Klintmalm GB et al. |
Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group. |
1993 |
Transplant. Proc. |
pmid:7679828
|
Jusko WJ and D'Ambrosio R |
Monitoring FK 506 concentrations in plasma and whole blood. |
1991 |
Transplant. Proc. |
pmid:1721260
|
Lane BC et al. |
Evaluation of calcineurin's role in the immunosuppressive activity of FK 506, related macrolactams, and cyclosporine. |
1993 |
Transplant. Proc. |
pmid:7679829
|
Wachtman GS et al. |
Biologics and donor bone marrow cells for targeted immunomodulation in vascularized composite allotransplantation: a translational trial in swine. |
2011 |
Transplant. Proc. |
pmid:22099837
|
Venkataramanan R et al. |
Pharmacokinetics of FK 506 in transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721261
|
Neylan JF |
Effect of race and immunosuppression in renal transplantation: three-year survival results from a US multicenter, randomized trial. FK506 Kidney Transplant Study Group. |
1998 |
Transplant. Proc. |
pmid:9636551
|
Tanabe K et al. |
ABO-incompatible living donor kidney transplantation under tacrolimus immunosuppression. |
2000 |
Transplant. Proc. |
pmid:11119903
|
Christians U et al. |
High performance liquid chromatography/mass spectrometry of FK 506 and its metabolites in blood, bile, and urine of liver grafted patients. |
1991 |
Transplant. Proc. |
pmid:1721262
|
Washburn WK et al. |
Tacrolimus rescue therapy for renal allograft rejection refractory to cyclosporine-based immunosuppression. |
1996 |
Transplant. Proc. |
pmid:8623214
|
Fitzsimmons WE et al. |
Demographic considerations in tacrolimus pharmacokinetics. |
1998 |
Transplant. Proc. |
pmid:9636552
|
Jang HJ et al. |
Conversion from cyclosporine to tacrolimus in renal allograft recipients with delayed graft function from severe acute tubular necrosis. |
2000 |
Transplant. Proc. |
pmid:11119904
|
Regazzi MB et al. |
Interaction between FK 506 and diltiazem in an animal model. |
1996 |
Transplant. Proc. |
pmid:8623215
|
Elmer DS et al. |
Metabolic effects of FK 506 (tacrolimus) versus cyclosporine in portally drained pancreas allografts. |
1998 |
Transplant. Proc. |
pmid:9532159
|
Chakkera HA et al. |
Genetic differences in Native Americans and tacrolimus dosing after kidney transplantation. |
2013 Jan-Feb |
Transplant. Proc. |
pmid:23375287
|
Burke GW et al. |
Tacrolimus-related microangiopathy in kidney and simultaneous pancreas-kidney recipients: evidence of endothelin and cytokine involvement. |
1998 |
Transplant. Proc. |
pmid:9532223
|
Sahar G et al. |
Glucose metabolism in heart transplant recipients treated with FK506 or cyclosporine. |
2003 |
Transplant. Proc. |
pmid:12644092
|
Vilalta R et al. |
Delayed graft function is reduced with antithymocyte globulin induction in pediatric kidney transplantation. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715923
|
Sgrosso JL et al. |
Tacrolimus pharmacokinetics in heart transplant. |
2002 |
Transplant. Proc. |
pmid:11959225
|
Žilinská Z et al. |
Impact of Trough Levels of Tacrolimus on Kidney Function and Graft Survival in Short and Longer Periods After Renal Transplantation. |
2016 |
Transplant. Proc. |
pmid:27788794
|
Kay JE et al. |
The mechanism of action of FK 506. |
1990 |
Transplant. Proc. |
pmid:1689914
|
Schreiber SL et al. |
Immunophilin-ligand complexes as probes of intracellular signaling pathways. |
1991 |
Transplant. Proc. |
pmid:1721293
|
Butt TR et al. |
Molecular basis of immunosuppressive drug action: regulation of steroid receptor-mediated transcription by FK 506. |
1996 |
Transplant. Proc. |
pmid:8623486
|
Mueller AR et al. |
Influence of immunosuppression on patient outcome after liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636608
|
Yoshida S et al. |
Combination therapy with FK 506 and RS61443 for rejection following allogeneic small bowel transplantation in rats. |
2000 |
Transplant. Proc. |
pmid:11120262
|
Jordan ML et al. |
Outcome of tacrolimus conversion therapy for renal allograft rejection: 5-year follow-up. |
1999 |
Transplant. Proc. |
pmid:10576052
|
Nishikawa S et al. |
Extended mycophenolate mofetil administration beyond day 30 in allogeneic hematopoietic stem cell transplantation as preemptive therapy for severe graft-versus-host disease. |
2009 |
Transplant. Proc. |
pmid:19917404
|
Sathyan S et al. |
A case of recurrent immunotactoid glomerulopathy in an allograft treated with rituximab. |
2009 |
Transplant. Proc. |
pmid:19917422
|
Kaminska D et al. |
Mycophenolate mofetil but not the type of calcineurin inhibitor (cyclosporine vs tacrolimus) influences the intragraft mRNA expression of cytokines in human kidney allograft biopsies by in situ RT-PCR analysis. |
2005 |
Transplant. Proc. |
pmid:15848526
|
Pérez-Flores I et al. |
Incidence and risk factors for the metabolic syndrome and posttransplant diabetes in renal transplant recipients taking tacrolimus. |
2010 |
Transplant. Proc. |
pmid:20970565
|
Marzoa-Rivas R et al. |
Conversion of heart transplant patients from standard to sustained-release tacrolimus requires a dosage increase. |
2010 |
Transplant. Proc. |
pmid:20970591
|
Marzorati S et al. |
Effects of systemic immunosuppression on islet engraftment and function into a subcutaneous biocompatible device. |
2009 Jan-Feb |
Transplant. Proc. |
pmid:19249555
|
Lodewijk L et al. |
Effect of liver regeneration on the pharmacokinetics of immunosuppressive drugs. |
2009 Jan-Feb |
Transplant. Proc. |
pmid:19249561
|
Imai K et al. |
Pancreaticoduodenal allotransplantation with the use of FK 506, cyclosporine, and triple-regimen immunosuppression. |
1990 |
Transplant. Proc. |
pmid:1697117
|
Spada M et al. |
Morphology of acute rejection and observation of lymphoproliferative hyperplastic reaction in FK 506 treated pigs after small bowel transplantation. |
1994 |
Transplant. Proc. |
pmid:7518142
|
Kai N et al. |
A study on the timing of immunologic priming in autoimmune insulitis in NOD mice. |
1992 |
Transplant. Proc. |
pmid:1376511
|
Langrehr JM et al. |
Liver transplantation in hepatitis B surface antigen positive patients with postoperative long-term immunoprophylaxis. |
1995 |
Transplant. Proc. |
pmid:7533373
|
Nakata S et al. |
Immunosuppressive effect of FK 506 on cytotoxic T lymphocytes and delayed-type hypersensitivity in rats. |
1991 |
Transplant. Proc. |
pmid:1721325
|
Liu B et al. |
Single-center experience: tacrolimus and mycophenolate mofetil in early stage of kidney transplantation with liver dysfunction. |
2003 |
Transplant. Proc. |
pmid:12591396
|
Iwahori T et al. |
Pharmacokinetic differences between morning and evening administration of cyclosporine and tacrolimus therapy. |
2005 |
Transplant. Proc. |
pmid:15919450
|
Varo E et al. |
Cardiovascular risk factors in liver allograft recipients: relationship with immunosuppressive therapy. |
2002 |
Transplant. Proc. |
pmid:12176481
|
Winkler M et al. |
Comparison of plasma vs whole blood as matrix for FK 506 drug level monitoring. |
1995 |
Transplant. Proc. |
pmid:7533433
|
Odoul F et al. |
Massive ingestion of tacrolimus in a young liver transplant patient. |
1998 |
Transplant. Proc. |
pmid:9865375
|
Van Thiel DH et al. |
Interferon therapy of hepatitis following liver transplantation under FK 506 or cyclosporine. |
1991 |
Transplant. Proc. |
pmid:1721357
|
EscartÃn A et al. |
Analysis of pig-MAP after small bowel transplantation in pigs. |
1998 |
Transplant. Proc. |
pmid:9865377
|
Weber M et al. |
Decreased rejection episodes in African-American renal transplant recipients receiving mycophenolate mofetil/tacrolimus therapy. |
1997 |
Transplant. Proc. |
pmid:9414883
|
Parada MT et al. |
Everolimus in lung transplantation in Chile. |
2010 Jan-Feb |
Transplant. Proc. |
pmid:20172343
|
Armitage JM et al. |
The clinical trial of FK 506 as primary and rescue immunosuppression in adult cardiac transplantation. |
1991 |
Transplant. Proc. |
pmid:1721358
|
Scantlebury VP et al. |
Outcome of kidney transplantation in African-Americans using tacrolimus. |
1997 |
Transplant. Proc. |
pmid:9414906
|
Deniz H et al. |
Inhibition of the renin angiotensin system decreases fibrogenic cytokine expression in tacrolimus nephrotoxicity in rats. |
2006 |
Transplant. Proc. |
pmid:16549154
|
Nalesnik MA et al. |
Lymphoproliferative disorders arising under immunosuppression with FK 506: initial observations in a large transplant population. |
1991 |
Transplant. Proc. |
pmid:1703335
|
Weimer R et al. |
Effects of three immunosuppressive regimens on CD4 helper function, B cell monocyte and cytokine responses in renal transplant recipients: 4-month follow-up of a prospective randomized study. |
2002 |
Transplant. Proc. |
pmid:12270445
|
Fisniku O et al. |
Protective effects of PG490-88 on chronic allograft rejection by changing intragraft gene expression profiles. |
2005 |
Transplant. Proc. |
pmid:15919518
|
Jiménez O et al. |
Defining the initial doses of sirolimus and tacrolimus in the period immediately after renal transplantation. |
2003 |
Transplant. Proc. |
pmid:12962758
|
Cotovio P et al. |
New-onset diabetes after transplantation: assessment of risk factors and clinical outcomes. |
2013 |
Transplant. Proc. |
pmid:23622631
|
Cronin DC et al. |
Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123010
|
Fahlke J et al. |
Staggered immunosuppression with the interleukin-2 receptor antagonist daclizumab combined with tacrolimus, prednisolone, and mycophenolate mofetil after orthotopic liver transplantation: a pilot efficacy and safety study. |
2002 |
Transplant. Proc. |
pmid:12072328
|
Zhu Y et al. |
Prolongation of canine renal allograft survival by combining tacrolimus with antimetabolic agents. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123011
|
Uchida K et al. |
Excellent 3-year results following living-donor kidney transplantation and tacrolimus immunosuppression in Japan. |
2002 |
Transplant. Proc. |
pmid:12176503
|
Teebken OE et al. |
Primary immunosuppression with tacrolimus and mycophenolate mofetil versus cyclosporine and azathioprine in heart transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12072335
|
Rossi G et al. |
Results of orthotopic liver-small bowel transplantation in the pig using different immunosuppressive regimens. |
1996 |
Transplant. Proc. |
pmid:8907932
|
Burke GW et al. |
Randomized trial of three different immunosuppressive regimens to prevent chronic renal allograft rejection. |
2002 |
Transplant. Proc. |
pmid:12176505
|
Platz KP et al. |
Immunosuppressive power and limitations of FK 506 for prevention and treatment of graft-vs-host disease after small bowel transplantation. |
1996 |
Transplant. Proc. |
pmid:8907933
|
Meçule A et al. |
Tacrolimus trough levels and level-to-dose ratio in stable renal transplant patients converted to a once-daily regimen. |
2011 |
Transplant. Proc. |
pmid:21620042
|
Guy S et al. |
Successful treatment of acute severe graft-versus-host-disease in a pancreas-after-kidney transplant recipient: case report. |
2014 |
Transplant. Proc. |
pmid:25179161
|
Kaufman DB et al. |
Single-center experience of 60 consecutive simultaneous pancreas-kidney transplants using mycophenolate mofetil and tacrolimus as primary maintenance immunotherapy. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083261
|
Takagishi K et al. |
Effects of FK-506 on collagen arthritis in mice. |
1989 |
Transplant. Proc. |
pmid:2468205
|
Schmidt RJ et al. |
Hemolytic-uremic syndrome in a renal transplant recipient on FK 506 immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721390
|
Personett HA et al. |
Impact of molecular adsorbent recirculating system therapy on tacrolimus elimination: a case report. |
2014 |
Transplant. Proc. |
pmid:25017243
|
Guo Z et al. |
Leflunomide, a potential immunosuppressant for pancreatic islet transplantation. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123314
|
Gerhardt U et al. |
High QT dispersion in tacrolimus-treated kidney transplant recipients. |
2001 |
Transplant. Proc. |
pmid:11377482
|
Golling M et al. |
Tacrolimus reduction improves glucose metabolism and insulin secretion after liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8962234
|
Toda F et al. |
Tacrolimus trough level adjustment after administration of fluconazole to kidney recipients. |
2002 |
Transplant. Proc. |
pmid:12176555
|
Ju MK et al. |
A 6-month, open-label, multicenter clinical study in Korean de novo renal transplant patients evaluating the efficacy, safety, and tolerance of myfortic concomitantly used with tacrolimus. |
2012 |
Transplant. Proc. |
pmid:22310600
|
Iwamoto H et al. |
Early steroid withdrawal in adult kidney transplantation at a single center. |
2012 |
Transplant. Proc. |
pmid:22310609
|
Berloco P et al. |
Tacrolimus as cornerstone immunosuppressant in kidney transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267161
|
Ciancio G et al. |
Daclizumab induction for primary kidney transplant recipients using tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267169
|
Cooper MH et al. |
The induction of pseudo-graft-versus-host disease following syngeneic bone marrow transplantation using FK 506. |
1991 |
Transplant. Proc. |
pmid:1721419
|
Yagura K et al. |
Pharmacokinetic characteristics of two types of liposomal FK 506. |
1996 |
Transplant. Proc. |
pmid:8658708
|
Shi Y et al. |
Comparison of Mizoribine and Mycophenolate Mofetil With a Tacrolimus-Based Immunosuppressive Regimen in Living-Donor Kidney Transplantation Recipients: A Retrospective Study in China. |
|
Transplant. Proc. |
pmid:28104150
|
Boggs S et al. |
FK 506 has no short-term effects on endogenous or exogenous myeloid reconstitution in irradiated mice. |
1991 |
Transplant. Proc. |
pmid:1721420
|
Ogawa N et al. |
Suppressive effects of combination therapy with mizoribine and FK 506 on the development of accelerated coronary artery disease and myocardial rejection after heart transplantation. |
1996 |
Transplant. Proc. |
pmid:8658710
|
Pan D et al. |
Tacrolimus-associated Diffuse Gastrointestinal Ulcerations and Pathergy: A Case Report. |
|
Transplant. Proc. |
pmid:28104141
|
Dick TB et al. |
Fludrocortisone is effective in the management of tacrolimus-induced hyperkalemia in liver transplant recipients. |
2011 |
Transplant. Proc. |
pmid:21911143
|
Zucker MJ et al. |
De novo immunosuppression with sirolimus and tacrolimus in heart transplant recipients compared with cyclosporine and mycophenolate mofetil: a one-year follow-up analysis. |
2005 |
Transplant. Proc. |
pmid:15964386
|
Gridelli B et al. |
Frequency of switch from cyclosporine to FK 506 before and after Neoral use in pediatric liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9723311
|
Wiseman AC et al. |
Fixed-dose sirolimus with reduced dose calcineurin inhibitor: the University of Colorado experience. |
2003 |
Transplant. Proc. |
pmid:12742482
|
Webb NJ et al. |
Pharmacokinetics of tacrolimus in paediatric renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176639
|
Collin C et al. |
Sublingual tacrolimus as an alternative to intravenous route in patients with thoracic transplant: a retrospective study. |
2010 |
Transplant. Proc. |
pmid:21168693
|
Shokouh-Amiri MH et al. |
The importance of early prevention of renal dysfunction in liver transplant recipients. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267345
|
Reiner J et al. |
After Intestinal Transplantation Kidney Function Is Impaired by Downregulation of Epithelial Ion Transporters in the Ileum. |
2016 |
Transplant. Proc. |
pmid:27109987
|
Thomson AW et al. |
Influence of FK 506 on T lymphocytes, Langerhans' cells and the expression of cytokine receptors and adhesion molecules in psoriatic skin lesions: a preliminary study. |
1991 |
Transplant. Proc. |
pmid:1721452
|
GarcÃa González M et al. |
Reversal of QT interval electrocardiographic alterations in cirrhotic patients undergoing liver transplantation. |
1999 |
Transplant. Proc. |
pmid:10500620
|
Todo S et al. |
Effect of FK506 in experimental organ transplantation. |
1988 |
Transplant. Proc. |
pmid:2450416
|
Calne RY |
Immunosuppression for organ grafting. |
1991 |
Transplant. Proc. |
pmid:1714646
|
Starzl TE et al. |
Notes on FK 506. |
1991 |
Transplant. Proc. |
pmid:1714647
|
Yoshimura R et al. |
A comparative study between cyclosporine and FK 506 effects on renal microsomal P-450. |
1991 |
Transplant. Proc. |
pmid:1703686
|
Kinukawa T et al. |
Long-term comparison of tacrolimus and cyclosporine-based immunosuppression in kidney recipients with grafts from non-heart-beating cadaver donor. |
1998 |
Transplant. Proc. |
pmid:9636498
|
Alak AM and Moy S |
Biological activity of tacrolimus (FK506) and its metabolites from whole blood of kidney transplant patients. |
1997 |
Transplant. Proc. |
pmid:9270821
|